Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Wordsworth

Showing results (101-110 of 141) with videos related to

Pageof 15
Sort By:
BMJ Open|June 7, 2019
Comprehensive ascertainment of bleeding in patients prescribed different combinations of dual antiplatelet therapy (DAPT) and triple therapy (TT) in the UK: study protocol for three population-based cohort studies emulating 'target trials' (the ADAPTT Study)Maria Pufulete, Jessica Harris, Jonathan A C Sterne, et al.
European Journal of Human Genetics : EJHG|April 27, 2021
Toward the diagnosis of rare childhood genetic diseases: what do parents value most?Samantha Pollard, Deirdre Weymann, Jessica Dunne, et al.
BMC Medicine|July 31, 2020
Why do hospital prescribers continue antibiotics when it is safe to stop? Results of a choice experiment surveyLaurence S J Roope, James Buchanan, Liz Morrell, et al.
Health Technology Assessment (Winchester, England)|August 23, 2014
Can rapid integrated polymerase chain reaction-based diagnostics for gastrointestinal pathogens improve routine hospital infection control practice? A diagnostic studyLouise Pankhurst, Louissa Macfarlane-Smith, James Buchanan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 12, 2021
Content of Health Economics Analysis Plans (HEAPs) for Trial-Based Economic Evaluations: Expert Delphi Consensus SurveyJoanna C Thorn, Charlotte F Davies, Sara T Brookes, et al.
ESMO Open|February 22, 2020
Rationale and design of the POLEM trial: avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III mismatch repair deficient or POLE exonuclease domain mutant colon cancer: a phase III randomised studyDavid Lau, Eleftheria Kalaitzaki, David N Church, et al.
Health Technology Assessment (Winchester, England)|July 12, 2023
Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studiesJessica Harris, Koen B Pouwels, Thomas Johnson, et al.
Health Technology Assessment (Winchester, England)|November 5, 2016
The Effectiveness, cost-effectiveness and acceptability of Community versus Hospital Eye Service follow-up for patients with neovascular age-related macular degeneration with quiescent disease (ECHoES): a virtual randomised balanced incomplete block trialBarnaby C Reeves, Lauren J Scott, Jodi Taylor, et al.
Plos Medicine|February 15, 2017
Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health ServiceAngela Hamblin, Sarah Wordsworth, Jilles M Fermont, et al.
Resuscitation|November 7, 2016
Design and implementation of the AIRWAYS-2 trial: A multi-centre cluster randomised controlled trial of the clinical and cost effectiveness of the i-gel supraglottic airway device versus tracheal intubation in the initial airway management of out of hospital cardiac arrestJodi Taylor, Sarah Black, Stephen J Brett, et al.
Pageof 15

Showing results (101-110 of 141) with videos related to

Sort By:
Pageof 15
BMJ Open|June 7, 2019
Comprehensive ascertainment of bleeding in patients prescribed different combinations of dual antiplatelet therapy (DAPT) and triple therapy (TT) in the UK: study protocol for three population-based cohort studies emulating 'target trials' (the ADAPTT Study)Maria Pufulete, Jessica Harris, Jonathan A C Sterne, et al.
European Journal of Human Genetics : EJHG|April 27, 2021
Toward the diagnosis of rare childhood genetic diseases: what do parents value most?Samantha Pollard, Deirdre Weymann, Jessica Dunne, et al.
BMC Medicine|July 31, 2020
Why do hospital prescribers continue antibiotics when it is safe to stop? Results of a choice experiment surveyLaurence S J Roope, James Buchanan, Liz Morrell, et al.
Health Technology Assessment (Winchester, England)|August 23, 2014
Can rapid integrated polymerase chain reaction-based diagnostics for gastrointestinal pathogens improve routine hospital infection control practice? A diagnostic studyLouise Pankhurst, Louissa Macfarlane-Smith, James Buchanan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 12, 2021
Content of Health Economics Analysis Plans (HEAPs) for Trial-Based Economic Evaluations: Expert Delphi Consensus SurveyJoanna C Thorn, Charlotte F Davies, Sara T Brookes, et al.
ESMO Open|February 22, 2020
Rationale and design of the POLEM trial: avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III mismatch repair deficient or POLE exonuclease domain mutant colon cancer: a phase III randomised studyDavid Lau, Eleftheria Kalaitzaki, David N Church, et al.
Health Technology Assessment (Winchester, England)|July 12, 2023
Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studiesJessica Harris, Koen B Pouwels, Thomas Johnson, et al.
Health Technology Assessment (Winchester, England)|November 5, 2016
The Effectiveness, cost-effectiveness and acceptability of Community versus Hospital Eye Service follow-up for patients with neovascular age-related macular degeneration with quiescent disease (ECHoES): a virtual randomised balanced incomplete block trialBarnaby C Reeves, Lauren J Scott, Jodi Taylor, et al.
Plos Medicine|February 15, 2017
Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health ServiceAngela Hamblin, Sarah Wordsworth, Jilles M Fermont, et al.
Resuscitation|November 7, 2016
Design and implementation of the AIRWAYS-2 trial: A multi-centre cluster randomised controlled trial of the clinical and cost effectiveness of the i-gel supraglottic airway device versus tracheal intubation in the initial airway management of out of hospital cardiac arrestJodi Taylor, Sarah Black, Stephen J Brett, et al.
Pageof 15